
Jazz Pharmaceuticals plc JAZZ
$ 248.31
1.19%
Jazz Pharmaceuticals plc DIO Ratio | JAZZ
Annual DIO Ratio Jazz Pharmaceuticals plc
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 224 | 159 | 143 | 118 | 69.4 | 93.3 | 103 | 123 | 102 | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 224 | 69.4 | 126 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AbbVie
ABBV
|
91.6 | $ 294.72 | 0.32 % | $ 521 B | ||
|
Axon Enterprise
AXON
|
98.8 | $ 316.97 | 4.77 % | $ 24.7 B | ||
|
Bristol-Myers Squibb Company
BMY
|
68.7 | $ 62.89 | 0.18 % | $ 128 B | ||
|
Adaptimmune Therapeutics plc
ADAP
|
19.1 K | - | -15.15 % | $ 60.3 M | ||
|
Dynavax Technologies Corporation
DVAX
|
455 | - | - | $ 2.02 B | ||
|
Alnylam Pharmaceuticals
ALNY
|
43.5 | $ 159.75 | 5.35 % | $ 20.9 B | ||
|
Amgen
AMGN
|
200 | $ 467.97 | 0.59 % | $ 252 B | ||
|
Orgenesis
ORGS
|
3.22 | - | -33.86 % | $ 61.2 M | ||
|
Johnson & Johnson
JNJ
|
161 | $ 280.31 | -0.17 % | $ 675 B | ||
|
Kala Pharmaceuticals
KALA
|
602 | $ 0.17 | 0.64 % | $ 1.39 M | ||
|
Lineage Cell Therapeutics
LCTX
|
0.33 | $ 1.13 | 8.17 % | $ 260 M | ||
|
Paratek Pharmaceuticals
PRTK
|
218 | - | - | $ 121 M | ||
|
Eli Lilly and Company
LLY
|
352 | $ 1 437.4 | 0.36 % | $ 1.29 T | ||
|
Crinetics Pharmaceuticals
CRNX
|
343 | $ 84.95 | 0.13 % | $ 7.99 B | ||
|
AVEO Pharmaceuticals
AVEO
|
149 | - | - | $ 521 M | ||
|
Seelos Therapeutics
SEEL
|
71.7 | - | -47.76 % | $ 6.27 M | ||
|
Moderna
MRNA
|
56.8 | $ 248.62 | -0.88 % | $ 96.7 B | ||
|
CollPlant Biotechnologies Ltd.
CLGN
|
221 | $ 3.96 | 1.41 % | $ 48.3 M | ||
|
Nektar Therapeutics
NKTR
|
95.8 | $ 38.41 | 1.67 % | $ 648 M | ||
|
CorMedix
CRMD
|
308 | $ 5.31 | -2.23 % | $ 383 K | ||
|
XTL Biopharmaceuticals Ltd.
XTLB
|
149 | $ 1.66 | -2.64 % | $ 1.12 B | ||
|
Deciphera Pharmaceuticals
DCPH
|
2.04 K | - | - | $ 2.18 B |